Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 15,54 € (+16,75%). La mediana è 15,54 € (+16,75%).
| Acquista |
9 |
| Mantieni |
4 |
| Vendi |
2 |
Notizie Vai al feed delle notizie
FIGS focuses on medical apparel and reports strong growth and margin jump
FIGS has specialized in clothing for medical professionals and leads the Apparel Manufacturing sector with a share price gain of over 54%. The company recorded revenue growth of more than 25% for the third consecutive quarter. In addition, the margin rose by over 8%, mainly due to duty refunds. » Altro su finanzen.net
FIGS slips despite strong quarter as shares fall on investor positioning
FIGS reported a strong Q1 with revenue of $159.9 million, up 28% year‑over‑year, U.S. revenue up 24% to $131.6 million and international revenue up 50% to $28.3 million. Active customers surpassed 3 million, up 12% year‑over‑year, and growth was broad‑based across products and regions. Despite the results, shares slipped largely due to investor positioning; the stock closed at $14.49 with a market cap of $2.41 billion and has risen 109.09% over the past 52 weeks. Baron Focused Growth Fund reiterated conviction in FIGS' direct‑to‑consumer model and market‑share potential. » Altro su finance.yahoo.com
Figs rises after profit doubles and sales accelerate
Figs reported Q2 sales up 29% to $196.6 million and GAAP net profit up about 300% year over year, with free cash flow turning positive at roughly $97 million over the past 12 months. The stock jumped about 27% on earnings and continued rising, while analysts at Barclays and KeyBanc raised price targets to $20 and Telsey lowered its target to $16. Figs trades at about 38x P/E but around 22x on an enterprise-value-to-FCF basis, a valuation the article argues is attractive given current growth rates. » Altro su finance.yahoo.com
Dati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 172,28 Mln | 33,03% |
| Utile lordo | 129,55 Mln | 49,34% |
| Utile netto | 24,87 Mln | 312,85% |
| EBITDA | 37,38 Mln | 210,63% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 2,19 Mld € |
Numero di azioni | 167,05 Mln |
Massimo/minimo a 52 settimane | 15,09 € - 5,61 € |
| Dividendi | No |
Beta | 1,02 |
Rapporto P/E | 41,00 |
Rapporto PEG | 0,06 |
Rapporto P/B | 5,73 |
Rapporto P/S | 3,58 |
Profilo aziendale
FIGS, Inc. ist in den Vereinigten Staaten als Direktvertriebsunternehmen für Bekleidung und Lifestyle im Gesundheitswesen tätig. Das Unternehmen entwirft und vertreibt Bekleidung für das Gesundheitswesen und andere Produkte, die nicht zur OP gehören, wie z. B. Laborkittel, OP-Kleidung, Oberbekleidung, Activewear, Loungewear, Kompressionssocken, Schuhe und Masken. Außerdem bietet das Unternehmen Sport-BHs, Performance-Leggings, Oberteile, superweiche Oberteile aus Pima-Baumwolle, Westen und Jacken an. Das Unternehmen vermarktet und verkauft seine Produkte über seine digitale Plattform, die eine Website und eine mobile App umfasst. FIGS, Inc. wurde im Jahr 2013 gegründet und hat seinen Hauptsitz in Santa Monica, Kalifornien.
| Nome | FIGS INC. CL.A DL-,0001 |
| CEO | Catherine Eva Spear |
| Sede centrale | Santa Monica,
ca Stati Uniti |
| Sito web | |
| Settore | Industria |
| Industria | Servizi e forniture commerciali |
| Quotazione in borsa | 27/05/2021 |
| Dipendenti | 359 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NYSE | FIGS |
Scopri gli asset
Gli azionisti di FIGS INC. CL.A DL-,0001 investono anche nei seguenti asset

